Industry

  PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today that top-line efficacy and safety results from GATHER2, the Company’s second Phase 3 clinical trial of avacincaptad pegol (ACP, also known as Zimura®), an investigational complement C5 inhibitor being evaluated for the treatment of geographic atrophy (GA), will be presented at the American Academy of … [Read more…]

BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. 27, 2022. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release … [Read more…]

LONDON–(BUSINESS WIRE)–$SLN #SenseofSilence–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that Giles Campion, MD, Head of R&D and Chief Medical Officer, will participate in a fireside … [Read more…]

KEYTRUDA now approved for 23 uses in 13 different types of cancer in Japan RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, received four new approvals from Japan’s Ministry of Health, Labor and Welfare (MHLW): KEYTRUDA in combination with chemotherapy … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–BizCap®, a national commercial finance and advisory firm, today announced it has successfully structured and secured $45 million in financing for its repeat client, Nivagen Pharmaceuticals, a specialty pharmaceuticals company engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. The credit … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Rehabilitation Robotics Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global rehabilitation robotics market. The global rehabilitation robotics market is expected to grow from $0.8 billion in 2021 to $0.96 billion in 2022 … [Read more…]

myPGx is the debut launch of LetsGetChecked’s new suite of genetics offerings, pioneering a full lifecycle of personalized, 360-degree healthcare from home NEW YORK–(BUSINESS WIRE)–LetsGetChecked, a leading healthcare solutions company, announced today the launch of its inaugural genetics offering, myPGx, a pharmacogenomics solution. myPGx enables prescribers to select medications with greater expectation of efficacy and … [Read more…]

OTX-TKI was Well Tolerated and Demonstrated a Favorable Safety Profile with no Drug-Related Ocular or Systemic Serious Adverse Events (SAEs) Sustained and Comparable CSFT and BCVA Measurements at 7 Months between OTK-TKI Treated Subjects and Aflibercept Treated Subjects 80% of Subjects were Rescue-Free up to 6 months and 73% of Subjects Were Rescue-Free up to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Artificial Organs and Medical Bionics Market – Global Industry Analysis (2019 – 2021) – Growth Trends and Market Forecast (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The world is witnessing a massive gap between the demand and supply imbalance of human organs. Notably, organ donors are far fewer than patients … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Lung Cancer Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Lung Cancer market. It covers emerging therapies for Lung Cancer in active clinical development stages including early and late stage clinical trials. The … [Read more…]